Clinical trial
A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an…
NCT00381212 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Completed
Key facts
| NCT number | NCT00381212 |
|---|---|
| Title | A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. |
| Official title | A Pilot Study (Phase I/II) Testing the Immunologic Activity and Safety of AGS-004, an Autologous HIV Immunotherapeutic, in HIV-Infected Adults on HAART |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Collaborators | Université de Montréal Argos Therapeutics Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Seropositivity, Acquired Immunodeficiency Syndrome |
| Intervention type | Biological |
| Interventions | AGS-004 |
| Enrollment | 10 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 27, 2006 |
| Last update posted | Jan 29, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: